financing
Lucid Diagnostics Raises $22M in Convertible Debt Refinancing
The cash raised brings the company’s total holdings to about $33 million, enough to see it through plans to gain reimbursement for its esophageal cancer test.
The company, based outside of Grenoble in the French Alps, together with its partners has received €5 million to pursue the project.
OneCell Diagnostics Raises $16M in Series A Round
The precision oncology company plans to bring its OncoIndx Ikon liquid biopsy circulating tumor cell detection test to the US market.
PrognomiQ Closes $34M Series D Round
The company said it will use the funding for development of its blood-based early detection test for lung cancer, which it plans to offer initially as an LDT and then as an IVD.
Backed by $184M in Recent Funding, Cytovale Aims to Bring Its Sepsis Risk Test Into More ERs
Premium
The firm said that demand has increased for its 10-minute sepsis risk test as it can save lives, reduce hospital stays, and reduce healthcare costs.
Oct 10, 2024
Cytovale Raises $100M in Series D Round
Oct 10, 2024
Sep 24, 2024
Labcorp Closes $2B Senior Notes Public Offering
Jun 18, 2024
Rarity Bioscience Closes $7M Funding Round
Feb 14, 2024